Scarica l'app Stockscreener
36.34
0.33%
-0.12
Dopo l'orario di chiusura:
36.34
Precedente Chiudi:
$36.46
Aprire:
$36.95
Volume 24 ore:
3.25M
Relative Volume:
2.48
Capitalizzazione di mercato:
$1.96B
Reddito:
$2.82B
Utile/perdita netta:
$-1.87B
Rapporto P/E:
-1.3025
EPS:
-27.9
Flusso di cassa netto:
$-96.80M
1 W Prestazione:
+24.79%
1M Prestazione:
+25.96%
6M Prestazione:
-16.94%
1 anno Prestazione:
-16.69%
Intervallo 1D:
$35.45
$36.95
Intervallo di 1 settimana:
$25.65
$37.24
Portata 52W:
$23.77
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
Nome
Quidelortho Corporation
Settore
Industria
Telefono
(858) 552-1100
Indirizzo
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Confronta QDEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
36.34 | 1.96B | 2.82B | -1.87B | -96.80M | -27.90 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-09-19 | Ripresa | UBS | Neutral |
| 2024-09-05 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2024-03-04 | Downgrade | UBS | Neutral → Sell |
| 2024-02-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-14 | Aggiornamento | UBS | Sell → Neutral |
| 2022-09-19 | Iniziato | Citigroup | Neutral |
| 2022-07-20 | Iniziato | UBS | Sell |
| 2022-06-17 | Ripresa | JP Morgan | Neutral |
| 2022-02-22 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-03-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Reiterato | Barclays | Overweight |
| 2018-01-04 | Aggiornamento | CL King | Neutral → Buy |
| 2017-09-19 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Reiterato | Canaccord Genuity | Hold |
| 2017-02-17 | Iniziato | CL King | Neutral |
| 2016-12-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Reiterato | Barclays | Overweight |
| 2016-02-09 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Reiterato | Canaccord Genuity | Buy |
| 2015-12-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Iniziato | Barclays | Overweight |
| 2013-07-31 | Reiterato | Canaccord Genuity | Buy |
| 2011-03-03 | Downgrade | Wedbush | Outperform → Neutral |
Mostra tutto
Quidelortho Corporation Borsa (QDEL) Ultime notizie
Quidelortho sees $30M-$40M tariff impact offset, maintains 2025 guidance - MSN
QuidelOrtho Stock Gains Following Q1 Earnings Beat, Margins Expand - MSN
QuidelOrtho First Quarter 2025 Earnings: EPS Beats Expectations - simplywall.st
Jefferies upgrades QuidelOrtho to Buy, says ‘no news is good news’ - TipRanks
10 Unexpected Market Movers – What Propelled Double-Digit Gains? - Insider Monkey
Why QuidelOrtho Corporation (QDEL) Went Up On Thursday - Yahoo
QuidelOrtho Earnings Call: Growth Amid Challenges - TipRanks
Jefferies Upgrades QuidelOrtho (QDEL) - Nasdaq
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationQDEL - ACCESS Newswire
UBS Maintains Neutral Rating for QuidelOrtho (QDEL), Lowers Price Target | QDEL Stock News - GuruFocus
Why Is QuidelOrtho (QDEL) Stock Soaring Today - Yahoo Finance
Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
QuidelOrtho (QDEL) Upgraded to Buy by Jefferies | QDEL Stock News - GuruFocus
QuidelOrtho Shares Gain After Q1 Adjusted Earnings Beat Consensus - marketscreener.com
Jefferies Elevates QuidelOrtho (QDEL) to Buy Rating Amid Positive Outlook | QDEL Stock News - GuruFocus
UBS Reduces Price Target for QuidelOrtho (QDEL) to $29 | QDEL Stock News - GuruFocus
UBS Cuts Price Target on QuidelOrtho to $29 From $45, Keeps Neutral Rating - marketscreener.com
QuidelOrtho Corporation (NASDAQ:QDEL) Q1 2025 Earnings Call Transcript - Insider Monkey
QuidelOrtho revenue increases 5% to USD 693M in Q1 2025 - Medical Buyer
QuidelOrtho's Q1 CY2025 Financial Performance: Revenue Decline and Profit GrowthNews and Statistics - IndexBox
QuidelOrtho Q1 Adjusted Earnings Rise, Revenue Falls; Fiscal 2025 Guidance Maintained - marketscreener.com
QuidelOrtho Corp (QDEL) Q1 2025 Earnings Call Highlights: Strong Growth in Core Segments Amid ... - Yahoo Finance
QuidelOrtho Corp (QDEL) Q1 2025 Earnings Call Highlights: Strong Growth in Core Segments Amid Revenue Decline - GuruFocus
QuidelOrtho: Q1 Earnings Snapshot - Norwalk Hour
QuidelOrtho Reports Strong Q1 2025 Financial Results - TipRanks
QuidelOrtho Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: QuidelOrtho Q1 2025 beats EPS, stock up 7.5% - Investing.com Australia
QuidelOrtho Q1 2025 presentation slides: EPS surges 68% despite flat revenue - Investing.com
QDEL Confident in Minimizing Tariff Impacts | QDEL Stock News - GuruFocus
QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Reports Q1 In Line With Expectations, Stock Soars - Yahoo Finance
QuidelOrtho sees FY25 Labs business growth in mid-single digits - TipRanks
Quidel shares surge 7.8% as Q1 earnings beat estimates By Investing.com - Investing.com Nigeria
QuidelOrtho (QDEL) Projects Steady Growth Across Key Segments for 2025 | QDEL Stock News - GuruFocus
Quidel shares surge 7.8% as Q1 earnings beat estimates - Investing.com Australia
QuidelOrtho (QDEL) Exceeds Q1 Revenue Expectations | QDEL Stock News - GuruFocus
QuidelOrtho Corp Q1 2025 Earnings: Adjusted EPS of $0.74 Beats Estimates, Revenue Hits $693 Million Surpassing Projections - GuruFocus
(QDEL) QUIDELORTHO CORPORATION Sees Q2 Adjusted EPS Range $2.07$2.57 - marketscreener.com
QuidelOrtho Reports First Quarter 2025 Financial Results - Stock Titan
QuidelOrtho (QDEL) Earnings Expected to Grow: Should You Buy? - MSN
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN - TradingView
QuidelOrtho Earnings: What To Look For From QDEL - Yahoo Finance
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL)June 11, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Reminds QuidelOrtho Corporation f/k/a Quidel Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024QDEL - ACCESS Newswire
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) should contact Levi & Korsinsky about pending Class ActionQDEL - ACCESS Newswire
4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates - TradingView
QuidelOrtho Corporation (QDEL): Among Billionaire David Harding’s Stock Picks with Huge Upside Potential - Insider Monkey
Press Release Distribution & PR Platform - ACCESS Newswire
Why QuidelOrtho (QDEL) Could Beat Earnings Estimates Again - MSN
Quidelortho Corporation Azioni (QDEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):